Integrated cold chain Cryoport Systems offers an end-to-end, temperature-controlled life sciences supply chain platform, including logistics, biostorage, cryopreservation, and consulting. Sales opportunities exist in upselling integrated solutions to clients seeking risk mitigation, transparency, and scale across research through commercialization, especially for cell and gene therapies needing cold chain integrity.

European expansion Recent facility expansions in Pont-du-Château and the broader Western Europe growth position Cryoport for increased regional capacity. Target European biotech clusters and contract manufacturers with volume packaging, labeling, and GMP biorepository needs, emphasizing faster local support and regulatory-compliant import/QP services.

Clinical and regulatory services Beyond storage and logistics, Cryoport provides regulatory and Qualified Person services, importation, and release, as well as central lab sample management. Sales conversations can highlight the full-service nature to replace multiple vendors, reduce cycle times, and ensure compliant end-to-end handling for clinical trials and commercial launches.

Strategic alliances Notable partnerships and product launches, such as collaborations with fertility tech and investments in high-volume shipping solutions, indicate a push toward expanding capabilities. Opportunity to position Cryoport as a preferred partner for ecosystem players seeking coordinated supply chain solutions for complex biologics and offsite storage.

Innovation and awards Awards for supply chain excellence and development of Cryoport Express HV3 and IntegriCell services signal ongoing tech differentiation. Leverage these innovations to address customers’ needs for scalable, compliant, high-speed cold-chain shipping and advanced cryopreservation, particularly for high-value, time-sensitive therapies.